Rhythm Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Rhythm Pharmaceuticals Inc.: Is Infosys Ltd. worth buying?
Item: Rhythm Pharmaceuticals Inc.
Rating: 1.128722125
Author: Trendlyne DVM scores

Momentum Trap

about

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (...

88.89 -2.26 (-2.48%)

27.26% Fall from 52W High

422.8K

XNAS Volume

XNAS 13 Mar, 2026 10:50 AM (EDT)

Low Financial Strength

22.2 / 100

Expensive Valuation

4.8 / 100

Technically Neutral

41.0 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

141

1Yr Price target upside is 58%

15 analysts

Rhythm Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Rhythm Pharma Inc Live Stock Price Today, Share Analysis and Chart

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (...

27.26% Fall from 52W High

SWOT Analysis

Rhythm Pharma Inc Live Price Chart